drugset / Trial / NCT00509210
Study of Telaprevir in Subjects With Hepatic Impairment
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the safety and pharmacokinetics of Telaprevir following administration of multiple oral doses to subjects with moderate and severe hepatic impairment.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telaprevir | Small molecule | — | Oral |